BIO — BIO-RAD LABORATORIES, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 12208 ·
Last close
$377.69
Market Cap
$8.19B
52W High
$396.23
52W Low
$236.73
ADV30
269,459
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 651,000,000 | 345,800,000 | 72,600,000 | 371,400,000 | 10,252,000,000 | 517,000,000 | 3,078,100,000 |
| Mar 2026 | 592,100,000 | 309,400,000 | 34,100,000 | -527,100,000 | 9,790,000,000 | 507,200,000 | 2,938,700,000 |
| Dec 2025 | 693,200,000 | 345,200,000 | 53,900,000 | 720,000,000 | 10,576,500,000 | 529,800,000 | 3,122,900,000 |
| Sep 2025 | 653,000,000 | 343,400,000 | 63,900,000 | -341,900,000 | 9,696,400,000 | 395,800,000 | 2,959,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$492,600,000
Investing CF
$-237,100,000
Financing CF
$-120,800,000
CapEx
$-139,500,000
Dividends Paid
—
Buybacks
$-132,700,000
EPS Diluted TTM
$8.25
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$8,020,600,000
Inventory
$780,600,000
Receivables
$441,800,000
ST Investments
$1,101,500,000
EBIT TTM
$399,200,000
Pretax Income TTM
$350,400,000
Interest Exp TTM
$48,800,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,589,299,968
EBITDA
$441,000,000
Free Cash Flow
$283,187,488
Enterprise Value
$9,626,843,136
Total Cash
$1,618,499,968
Total Debt
$1,370,400,000
Shares Out
21,677,137
Trailing EPS
$8.20
Book Value
$268.30
ROE
3.1%
ROA
1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,583,200,000 | 218,600,000 | 759,900,000 | 10,576,500,000 | 3,122,900,000 | 7,453,600,000 | 532,200,000 |
| Dec 2024 | 2,566,500,000 | 269,000,000 | -1,844,200,000 | 9,364,100,000 | 2,794,800,000 | 6,569,300,000 | 455,200,000 |
| Dec 2023 | 2,671,200,000 | 337,800,000 | -637,300,000 | 12,299,100,000 | 3,557,900,000 | 8,741,200,000 | 374,900,000 |
| Dec 2022 | 2,802,200,000 | 475,100,000 | -3,627,500,000 | 13,501,666,000 | 3,886,414,000 | 9,615,252,000 | 194,400,000 |
TTM Snapshot
Revenues TTM
$2,470,200,000
NetIncome TTM
$1,434,400,000
OpCashFlow TTM
$0
Assets (Latest)
$10,576,500,000
Forward EPS
$10.03
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $390.00 · spot: $377.69 · call volume: 305 · put volume: 10
Expected Move to 2026-10-16:
±$20.10
(5.32%) —
implied range
$357.59 –
$397.79
· ATM straddle on $380.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MTLPF | Metlen Energy & Metals PLC/ADR | $8.16B | $57.30 | — |
| KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | $8.27B | $44.07 | — |
| MLSPF | Melrose Industries Plc/ADR | $8.06B | $6.47 | — |
| SPIWF | SPIE SA/ADR | $8.33B | $49.30 | — |
| SPIIY | SPIE SA/ADR | $8.37B | $12.38 | — |
News headlines (Yahoo Finance, 1h cache)
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth
2026-09-26 03:02 · Yahoo
Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius
2026-09-24 13:00 · Yahoo
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher
2026-09-24 10:34 · Yahoo
Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
2026-09-16 13:00 · Yahoo
Bio Rad (BIO) Stock Could Be 23% Overvalued As Column Expansion Continues
2026-09-15 00:20 · Yahoo
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
2026-09-10 11:03 · Yahoo
Bio-Rad (BIO) Up 11.7% Since Last Earnings Report: Can It Continue?
2026-09-03 15:30 · Yahoo
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference
2026-08-31 13:00 · Yahoo
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
2026-08-20 15:23 · Yahoo
Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
2026-08-14 00:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.